IRIS- DESyne X2 in the IRIS-DES Registry
Recruiting
Observational Study
Coronary Stenosis
Coronary Occlusion
Coronary Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 19 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Seung-Jung Park · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates effectiveness and safety of DESyne X2 in Routine Clinical Practice.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 19 and more
* Intervention with DeSyne X2 drug-eluting coronary stent
* Agreed with written informed consent form
Exclusion Criteria:
* Intervention with DeSyne X2 drug-eluting coronary stent and other drug eluting stent at the same time
* Life expectancy of 1year and un…
Contacts